Sanguisorbin B



Compound IDCDAMM01108
Common nameSanguisorbin B
IUPAC name1,2,6a,6b,9,9,12a-heptamethyl-10-(3,4,5-trihydroxyoxan-2-yl)oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid
Molecular formulaC35H56O7

Experimental data

Retention time12.25
Adduct[M+H]+
Actual mz589.403
Theoretical mz589.41
Error13.02
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7

Identifiers and class information

Inchi keyGZQIINDHMUJEAM-UHFFFAOYNA-N
SmilesO=C(O)C12CCC(C)C(C)C2C3=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC4(C)C3(C)CC1
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)588.823
Computed dipole moment(dipole)7.118
Total solvent accessible surface area (SASA)829.058
Hydrophobic component of SASA (FOSA)652.391
Hydrophilic component of SASA (FISA)164.443
Pie component of the SASA (PISA)12.224
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1726.68
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)10.5
Free energy of solvation of dipole (dip^2/V)0.0293413
Index of cohesive interaction in solids (ACxDN^.5/SA)0.02533
Globularity descriptor (glob)0.839567
Predicted polarizability in cubic angstroms (QPpolrz)59.212
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.056
Predicted octanol/gas partition coefficient (QPlogPoct)31.851
Predicted water/gas partition coefficient (QPlogPw)17.793
Predicted octanol/water partition coefficient (QPlogPo/w)4.762
Predicted aqueous solubility (QPlogS)-6.379
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.817
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.379
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)69.198
Predicted brain/blood partition coefficient (QPlogBB)-1.353
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)35.08
Predicted skin permeability, log Kp (QPlogKp)-3.931
PM3 calculated ionization potential (IP(ev))9.72
PM3 calculated electron affinity (EA(eV))-0.731
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)0.765
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)74.806
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)119.069
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q01064PDE1BPhosphodiesterase 1BT77613SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T77613DI0265Mild neurocognitive disorder[ICD-11: 6D71]Q01064PDE1B

Copyright © 2025